JMCVX
Price
$15.42
Change
+$0.12 (+0.78%)
Updated
Jun 6 closing price
Net Assets
1.89B
MVCAX
Price
$30.34
Change
+$0.32 (+1.07%)
Updated
Jun 6 closing price
Net Assets
16.67B
Interact to see
Advertisement

JMCVX vs MVCAX

Header iconJMCVX vs MVCAX Comparison
Open Charts JMCVX vs MVCAXBanner chart's image
Janus Henderson Mid Cap Value T
Price$15.42
Change+$0.12 (+0.78%)
VolumeN/A
Net Assets1.89B
MFS Mid Cap Value A
Price$30.34
Change+$0.32 (+1.07%)
VolumeN/A
Net Assets16.67B
JMCVX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMCVX vs. MVCAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCVX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.7B vs. JMCVX (1.89B). MVCAX pays higher dividends than JMCVX: MVCAX (0.89) vs JMCVX (0.69). JMCVX was incepted earlier than MVCAX: JMCVX (27 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than JMCVX (0.89). JMCVX is a more actively managed with annual turnover of: 37.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than JMCVX: MVCAX (1000) vs JMCVX (2500). JMCVX annual gain was more profitable for investors over the last year : -4.06 vs. MVCAX (-5.05). MVCAX return over 5 years is better than : 40.08 vs. JMCVX (11.79).
JMCVXMVCAXJMCVX / MVCAX
Total Expense Ratio0.890.9990%
Annual Report Gross Expense Ratio0.891.0089%
Fund Existence27 years24 years-
Gain YTD-1.734-2.15181%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.89B16.7B11%
Annual Yield % from dividends0.690.8977%
Returns for 1 year-4.06-5.0580%
Returns for 3 years-4.060.85-476%
Returns for 5 years11.7940.0829%
Returns for 10 years-16.7455.19-30%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDN5.940.46
+8.39%
Intellicheck
BNTC16.000.83
+5.47%
Benitec Biopharma
WMK76.021.94
+2.62%
Weis Markets
VNT36.090.28
+0.78%
Vontier Corp
BUD71.010.07
+0.10%
Anheuser-Busch INBEV SA/NV